256 related articles for article (PubMed ID: 21668792)
1. Comparison of the use of 5-fluorouracil and bevacizumab in primary trabeculectomy: results at 1 year.
Jurkowska-Dudzińska J; Kosior-Jarecka E; Zarnowski T
Clin Exp Ophthalmol; 2012; 40(4):e135-42. PubMed ID: 21668792
[TBL] [Abstract][Full Text] [Related]
2. Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study.
Akkan JU; Cilsim S
J Glaucoma; 2015 Jan; 24(1):1-8. PubMed ID: 23661044
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study.
Grewal DS; Jain R; Kumar H; Grewal SP
Ophthalmology; 2008 Dec; 115(12):2141-2145.e2. PubMed ID: 18692246
[TBL] [Abstract][Full Text] [Related]
4. Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: a pilot study.
Chua BE; Nguyen DQ; Qin Q; Ruddle JB; Wells AP; Niyadurupola N; Gupta V; Wong TT; Coote MA; Crowston JG
Clin Exp Ophthalmol; 2012 Nov; 40(8):773-9. PubMed ID: 22429268
[TBL] [Abstract][Full Text] [Related]
5. Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy.
Nilforushan N; Yadgari M; Kish SK; Nassiri N
Am J Ophthalmol; 2012 Feb; 153(2):352-357.e1. PubMed ID: 21982106
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial.
Sengupta S; Venkatesh R; Ravindran RD
J Glaucoma; 2012 Sep; 21(7):450-9. PubMed ID: 21543993
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Adjunctive Subconjunctival Bevacizumab on the Outcomes of Primary Trabeculectomy With Mitomycin C: A Prospective Randomized Placebo-controlled Trial.
Kiddee W; Orapiriyakul L; Kittigoonpaisan K; Tantisarasart T; Wangsupadilok B
J Glaucoma; 2015; 24(8):600-6. PubMed ID: 25393038
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study.
Kaushik J; Parihar JK; Jain VK; Gupta S; Nath P; Durgapal P; Ram J
Curr Eye Res; 2017 Feb; 42(2):217-224. PubMed ID: 27269279
[TBL] [Abstract][Full Text] [Related]
9. Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab: A Randomized Controlled Trial.
Fakhraie G; Ghadimi H; Eslami Y; Zarei R; Mohammadi M; Vahedian Z; Mafi M; Moghimi S
J Glaucoma; 2016 Mar; 25(3):e182-8. PubMed ID: 25493621
[TBL] [Abstract][Full Text] [Related]
10. Comparison of needle revision with subconjunctival bevacizumab and 5-fluorouracil injection of failed trabeculectomy blebs.
Simsek T; Cankaya AB; Elgin U
J Ocul Pharmacol Ther; 2012 Oct; 28(5):542-6. PubMed ID: 22731246
[TBL] [Abstract][Full Text] [Related]
11. The Singapore 5-fluorouracil trial: intraocular pressure outcomes at 8 years.
Wong MH; Husain R; Ang BC; Gazzard G; Foster PJ; Htoon HM; Wong TT; Oen FT; Khaw PT; Seah SK; Aung T
Ophthalmology; 2013 Jun; 120(6):1127-34. PubMed ID: 23466269
[TBL] [Abstract][Full Text] [Related]
12. Initial trabeculectomy with 5-fluorouracil with or without subconjunctival bevacizumab in the management of pseudoexfoliation glaucoma.
Elgin U; Sen E; Çolak S; Yılmazbas P
Int Ophthalmol; 2019 Jun; 39(6):1211-1217. PubMed ID: 29696466
[TBL] [Abstract][Full Text] [Related]
13. The effect of bevacizumab on the outcome of trabeculectomy with 5-Fluorouracil.
Suh W; Kee C
J Ocul Pharmacol Ther; 2013 Sep; 29(7):646-51. PubMed ID: 23621628
[TBL] [Abstract][Full Text] [Related]
14. The singapore 5-Fluorouracil trabeculectomy study: effects on intraocular pressure control and disease progression at 3 years.
Wong TT; Khaw PT; Aung T; Foster PJ; Htoon HM; Oen FT; Gazzard G; Husain R; Devereux JG; Minassian D; Tan SB; Chew PT; Seah SK
Ophthalmology; 2009 Feb; 116(2):175-84. PubMed ID: 19187822
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery.
Palanca-Capistrano AM; Hall J; Cantor LB; Morgan L; Hoop J; WuDunn D
Ophthalmology; 2009 Feb; 116(2):185-90. PubMed ID: 18930550
[TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
[TBL] [Abstract][Full Text] [Related]
17. Delayed post-operative use of 5-fluorouracil as an adjunct in medically uncontrolled open angle glaucoma.
Mastropasqua L; Carpineto P; Ciancaglini M; Zuppardi E; Lobefalo L; Gallenga PE
Eye (Lond); 1998; 12 ( Pt 4)():701-6. PubMed ID: 9850268
[TBL] [Abstract][Full Text] [Related]
18. Short-term results of initial trabeculectomy with intraoperative or postoperative 5-fluorouracil for primary glaucomas.
Lamba PA; Pandey PK; Raina UK; Krishna V
Indian J Ophthalmol; 1996 Sep; 44(3):157-60. PubMed ID: 9018993
[TBL] [Abstract][Full Text] [Related]
19. Intraocular pressure following combined routes of bevacizumab-augmented trabeculectomy for refractory neovascular glaucoma.
Chatterjee S; Rao A
Semin Ophthalmol; 2013 Mar; 28(2):72-4. PubMed ID: 23448559
[TBL] [Abstract][Full Text] [Related]
20. The size of subconjunctival preparation does not influence the outcome of trabeculectomy with mitomycin C.
Wasielica-Poslednik J; Hoffmann EM; Herzog D; Aliyeva S; Lamparter J; Pfeiffer N
J Glaucoma; 2015; 24(5):e75-9. PubMed ID: 25304277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
